PTC Therapeutics, Inc. (PTCT) Operating income 2016–2025
PTC Therapeutics, Inc. (PTCT) annual operating income history from SEC filings — each fiscal year as reported.
$866.9MFY2025 · since FY2016: -$132.1M → $866.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $866.9M | +386.5% |
| FY2024 | -$302.6M | +31.2% |
| FY2023 | -$439.5M | +1.8% |
| FY2022 | -$447.4M | -19.5% |
| FY2021 | -$374.4M | +13.3% |
| FY2020 | -$431.8M | -79.0% |
| FY2019 | -$241.2M | -108.5% |
| FY2018 | -$115.7M | -79.9% |
| FY2017 | -$64.3M | +51.3% |
| FY2016 | -$132.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice